Smith Group Asset Management LLC Makes New Investment in Nutex Health Inc. $NUTX

Smith Group Asset Management LLC purchased a new stake in Nutex Health Inc. (NASDAQ:NUTX) during the first quarter, HoldingsChannel.com reports. The fund purchased 13,087 shares of the company’s stock, valued at approximately $1,244,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Hussman Strategic Advisors Inc. acquired a new stake in shares of Nutex Health during the fourth quarter worth $3,457,000. SG Americas Securities LLC boosted its stake in Nutex Health by 3,232.6% in the 1st quarter. SG Americas Securities LLC now owns 30,360 shares of the company’s stock worth $2,885,000 after purchasing an additional 29,449 shares during the period. JPMorgan Chase & Co. boosted its stake in Nutex Health by 78.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 14,782 shares of the company’s stock worth $1,527,000 after purchasing an additional 6,476 shares during the period. World Investment Advisors bought a new position in Nutex Health during the 4th quarter worth about $266,000. Finally, Pacer Advisors Inc. increased its holdings in Nutex Health by 4.3% during the 4th quarter. Pacer Advisors Inc. now owns 33,289 shares of the company’s stock worth $5,480,000 after purchasing an additional 1,359 shares in the last quarter. Institutional investors and hedge funds own 5.32% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on NUTX shares. Wall Street Zen downgraded Nutex Health from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 20th. Lake Street Capital began coverage on Nutex Health in a research report on Tuesday, June 2nd. They set a “buy” rating and a $235.00 price objective for the company. B. Riley Financial started coverage on Nutex Health in a report on Friday, June 26th. They set a “buy” rating and a $290.00 price objective for the company. Zacks Research upgraded Nutex Health to a “hold” rating in a research note on Monday, June 29th. Finally, Weiss Ratings cut Nutex Health from a “hold (c+)” rating to a “hold (c)” rating in a research note on Friday, July 10th. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $243.33.

Nutex Health Stock Up 0.2%

Nutex Health stock opened at $149.03 on Wednesday. The company has a market cap of $1.03 billion, a P/E ratio of 11.52 and a beta of 0.21. Nutex Health Inc. has a 1-year low of $77.21 and a 1-year high of $204.00. The company has a fifty day simple moving average of $152.47 and a 200 day simple moving average of $130.03. The company has a current ratio of 3.14, a quick ratio of 3.12 and a debt-to-equity ratio of 0.66.

Nutex Health (NASDAQ:NUTX) last issued its quarterly earnings results on Thursday, April 30th. The company reported $6.52 EPS for the quarter, topping the consensus estimate of $3.99 by $2.53. Nutex Health had a net margin of 10.95% and a return on equity of 23.50%. The firm had revenue of $216.49 million for the quarter, compared to analysts’ expectations of $227.80 million. Research analysts anticipate that Nutex Health Inc. will post 22.72 earnings per share for the current fiscal year.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.